For citations:
Avxentyev N.A., Pazuhina E.M., Tumyan G.S., Zeynalova P.A. Pharmacoeconomic analysis of therapy with brentuximab vedotin, nivolumab and pembrolizumab in patients with relapsed Hodgkin’s lymphoma. Oncohematology. 2020;15(4):103-112. (In Russ.) https://doi.org/10.17650/1818-8346-2020-15-4-103-112